157 results
Page 2 of 8
424B5
bv3c3m
8 Nov 22
Prospectus supplement for primary offering
9:50pm
424B5
xr4gs5indsj hbfr
19 Aug 21
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
1rgznnm9m mm
14 Apr 21
Bio-Path Holdings Presents BP1002 Data at 2021 American Association for Cancer Research Annual Meeting
12:00am
8-K
EX-99.1
wsjloiapqqbm3y
11 Mar 21
Bio-Path Holdings to Present at the 2021 American Association for Cancer Research Annual Meeting
5:15pm
8-K
EX-99.1
j7gxdps ax549pvx
10 Mar 21
Bio-path Holdings Reports Full Year 2020 Financial Results
7:11am
424B5
sg8xoy5v wgsgexlccc
17 Feb 21
Prospectus supplement for primary offering
5:09pm
8-K
EX-99.1
48nss
19 Nov 20
Bio-Path Holdings Announces First Patient Dosed in Phase 1 Clinical Trial of BP1002
4:30pm
8-K
EX-99.1
1lt8w9yd5 ztb
22 Oct 20
Growing Patent Estate Creates Value and Supports Key Combination Therapies
4:30pm
424B5
7e4pnr47
14 Jul 20
Prospectus supplement for primary offering
6:03am
8-K
EX-99.1
gtmxiu 0iwzrxcjtk
14 May 20
Bio-Path Holdings to Present at the 2020 American Society of Clinical Oncology Annual Meeting
4:30pm
8-K
EX-99.1
o2a7pzpt
27 Apr 20
Bio-Path Holdings Presents at 2020 American Association for Cancer Research Annual Meeting
4:31pm